Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.

Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.

Oncotarget. 2018 Feb 27;9(16):13101

Authors: Ladju RB, Pascut D, Massi MN, Tiribelli C, Sukowati CHC

Abstract
[This corrects the article DOI: 10.18632/oncotarget.23359.].

PMID: 29569656 [PubMed - in process]

https://ift.tt/2pFoMYW